Licensed for intrathecal use
Products licensed for intrathecal use are the first line option and should be used wherever suitable.
There are no amikacin products licensed for intrathecal administration.
Not licensed for intrathecal use, limited information available
Products with partial information that are not licensed for intrathecal administration can still sometimes be used. Refer to the advice in our article and complete a risk assessment to enable you to interpret the details below and choose an appropriate product.
Hospira
Strength
Excipients
Sodium citrate, sodium metabisulfite (E223), water for injection
Osmolarity
No information
pH
3.5 – 5.5
Endotoxin content
No information
Neon Healthcare
Strength
Excipients
Sodium metabisulfite (E223), sodium citrate, sulfuric acid, water for injection
Osmolarity
No information
pH
3.5 – 5.5
Endotoxin content
No information
Tillomed Laboratories
Strength
Excipients
Sodium metabisulfite (E223), sodium citrate dihydrate, sulfuric acid, water for injection
Osmolarity
No information
pH
3.5 – 5.5
Endotoxin content
No information
Vianex
Strength
Excipients
Sodium metabisulfite (E223), sodium citrate, sulfuric acid, water for injection
Osmolarity
365 mOsmol/L
pH
3.5 – 5.5
Endotoxin content
≤ 0.33 EU/mg
Unlicensed ‘Special’, specified for intrathecal use
Unlicensed medicines that are manufactured in MHRA-licensed Specials Manufacturing Units, at the request of an authorised healthcare professional specifically for intrathecal use.
Royal Liverpool Hospitals NHS Foundation Trust
Amikacin Intrathecal Injection in sodium chloride 0.9%
Strength
25mg / 5mL